Skip to main content

Table 4 Health chronic problems declared by the study population

From: Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study

Chronic diseases

People with T2D

n (%)

People without diabetes

n (%)

p-value*

OR (95% CI)**

p-value**

Hypertension

250 (50.1)

79 (15.8)

<0.001

9.2 (5.0–16.9)

<0.001

Cardiovascular diseases

47 (9.4)

21 (4.2)

<0.01

1.9 (0.8–4.9)

<0.01

Peripheral neuropathy

271 (54.2)

117 (23.5)

<0.001

6.2 (3.4–11.3)

<0.001

Erectile dysfunction or loss of libido

143 (29.3)

52 (10.4)

<0.001

5.79 (2.7–12.2)

<0.001

Foot or leg ulcer/Amputation

30 (6)

9 (1.8)

<0.001

2.5 (0.7–8.4)

>0.05

Kidney diseases

39 (7.8)

18 (3.6)

<0.01

0.8 (0.3–2.3)

>0.05

Eyes diseases

49 (9.8)

21 (4.2)

<0.001

1.6 (0.7–3.4)

>0.05

Depression

25 (5)

7 (1.4)

<0.01

7.6 (1.4–65.9)

>0.05

Cancer

5 (1)

3 (0.6)

0.7

-

-

Lung diseases

28 (5.6)

27 (5.4)

1

0.8 (0.3–2.1)

>0.05

HIV/AIDSa

5 (1)

6 (1.2)

1

0.8 (0.2–3.8)

>0.05

Comorbidity number

  

<0.001***

  

 0

68 (13.6)

194 (38.8)

  

 1

122 (24.4)

174 (34.8)

  

  ≥ 2

310 (62)

132 (26.4)

  
  1. *p-value from paired t-test; **OR and p-value from multivariate logistic regression; ***p-value from the Stuart-Maxwell test
  2. aHIV/AIDS: Human Immunodeficiency Virus infection and Acquired Immune Deficiency Syndrome